Sign in

Koninklijke KPN N.V. KPN.AS

Price 4.05 EUR
as of 2026-09-04
48/100
Weak
Quality60
Growth42
Balance-sheet strength28
Valuation65
Momentum31
Income69

Composite 48/100; the shares have moved about 18% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Balance-sheet strength ranks 28/100 — a moderate mark against it.

Case for

Income ranks 69/100 — a moderate point in its favour. Valuation ranks 65/100 — a moderate point in its favour. Quality ranks 60/100 — a slight point in its favour.

Case against

Balance-sheet strength ranks 28/100 — a moderate mark against it. Momentum ranks 31/100 — a moderate mark against it. Growth ranks 42/100 — a slight mark against it.

What the company does Koninklijke KPN N.V. is a Dutch telecom and IT services provider operating fixed/mobile telephony, broadband, IT solutions, and wholesale network services under brands like KPN, XS4ALL, and Simyo.

Key financials KPN reports ROE 26.1%, ROA 7.3%, and ROCE 29.5% with gross/operating/net margins of 52.9%/23.0%/15.2%. Revenue and EPS growth are flat at 0.5% and 0.0%, respectively.

Stock health Quality scores high (71.2), but growth (39.0) and momentum (49.6) lag. Debt/equity is 2.18, net debt/EBITDA 2.85, and interest coverage 5.93; current ratio is 0.66.

Price vs fair value The stock trades at a PREMIUM of 19.20% to our fair-value estimate of 3.40 and a discount of 8.65% to the 12-month target of 4.57. - High profitability metrics (ROE 26.1%, ROCE 29.5%) support premium valuation (Sideravia). - Flat revenue/EPS growth (0.5%/0.0%) may justify discount vs target (company filings). - Forward P/E 15.97 vs trailing 19.09 signals valuation support (Valuation pillar 54.5). - Debt metrics (Debt/Equity 2.18, Net debt/EBITDA 2.85) temper upside (financials).

Looking forward Forward PEG of 0.82 suggests undemanding growth valuation, but weak momentum (RSI 49.70) and flat growth may cap near-term upside.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.